Ritu Gilhotra

1.0k total citations
61 papers, 721 citations indexed

About

Ritu Gilhotra is a scholar working on Pharmaceutical Science, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ritu Gilhotra has authored 61 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmaceutical Science, 11 papers in Molecular Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ritu Gilhotra's work include Advanced Drug Delivery Systems (15 papers), Drug Solubulity and Delivery Systems (12 papers) and Analytical Methods in Pharmaceuticals (7 papers). Ritu Gilhotra is often cited by papers focused on Advanced Drug Delivery Systems (15 papers), Drug Solubulity and Delivery Systems (12 papers) and Analytical Methods in Pharmaceuticals (7 papers). Ritu Gilhotra collaborates with scholars based in India, Australia and Malaysia. Ritu Gilhotra's co-authors include Debabrata Mishra, Gaurav Gupta, Pankaj Dangre, Neeraj Gilhotra, Sachin Kumar Singh, Waleed Hassan Almalki, Sami I. Alzarea, Abdulmalik Saleh Alfawaz Altamimi, Imran Kazmi and Kamal Dua and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Biological Macromolecules and Current Pharmaceutical Design.

In The Last Decade

Ritu Gilhotra

55 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ritu Gilhotra India 15 277 177 90 85 66 61 721
Mohammad Kashif Iqubal India 17 285 1.0× 316 1.8× 31 0.3× 70 0.8× 125 1.9× 44 1.2k
Ji-Hun Jang South Korea 16 164 0.6× 298 1.7× 57 0.6× 33 0.4× 102 1.5× 85 985
Lulu Wang China 15 118 0.4× 266 1.5× 31 0.3× 38 0.4× 57 0.9× 44 656
Sanjay Sharma India 17 141 0.5× 243 1.4× 41 0.5× 27 0.3× 40 0.6× 64 973
Seung‐Hyun Jeong South Korea 13 163 0.6× 161 0.9× 54 0.6× 26 0.3× 97 1.5× 67 640
Guru R. Valicherla India 19 112 0.4× 220 1.2× 22 0.2× 27 0.3× 68 1.0× 32 662
Mohammed Gulrez Zariwala United Kingdom 20 112 0.4× 286 1.6× 39 0.4× 34 0.4× 63 1.0× 48 938
Chun Tao China 18 117 0.4× 311 1.8× 30 0.3× 28 0.3× 67 1.0× 36 812
Arash Khorrami Iran 15 68 0.2× 229 1.3× 36 0.4× 27 0.3× 45 0.7× 32 617

Countries citing papers authored by Ritu Gilhotra

Since Specialization
Citations

This map shows the geographic impact of Ritu Gilhotra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Gilhotra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Gilhotra more than expected).

Fields of papers citing papers by Ritu Gilhotra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritu Gilhotra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Gilhotra. The network helps show where Ritu Gilhotra may publish in the future.

Co-authorship network of co-authors of Ritu Gilhotra

This figure shows the co-authorship network connecting the top 25 collaborators of Ritu Gilhotra. A scholar is included among the top collaborators of Ritu Gilhotra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritu Gilhotra. Ritu Gilhotra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liew, Kai Bin, Phei Er Kee, Long Chiau Ming, et al.. (2025). Nanoparticles as Novel Drug Delivery Systems for Cancer Treatment: Current Status and Future Perspectives. Current Pharmaceutical Design. 31(39). 3117–3127.
3.
Nandave, Mukesh, et al.. (2024). Unlocking β-cell restoration: The crucial role of PDX1 in diabetes therapy. Pathology - Research and Practice. 254. 155131–155131. 2 indexed citations
4.
Gilhotra, Ritu, et al.. (2024). Effect of Lyophilization on Characteristics of Iloperidone Nanosuspension. International Journal of Drug Delivery Technology. 14(2). 1039–1043. 1 indexed citations
5.
Patil, P.N., et al.. (2024). Hepatoprotective and Antioxidant Activity of Stem and Leaves Parts of Cissus woodrowii (Stapf ex Cooke) Santapau. International Journal of Pharmaceutical Quality Assurance. 15(2). 588–594. 1 indexed citations
6.
Gilhotra, Ritu, et al.. (2024). FORMULATION DEVELOPMENT AND EVALUATION OF PALIPERIDONE NANOSUSPENSION FOR SOLUBILITY ENHANCEMENT. International Journal of Applied Pharmaceutics. 173–181. 2 indexed citations
7.
Gupta, Gaurav, et al.. (2021). Phytochemical constituents, Ethno medicinal properties and Applications of Plant: Litsea glutinosa (Lour.) C.B. Robinson (Lauraceae). Research Journal of Pharmacy and Technology. 6113–6118. 4 indexed citations
8.
Gilhotra, Ritu, et al.. (2020). In vitro Antioxidant Potential and Cytotoxicity Study of Asparagus aethiopicus L. Extracts on HT-29 Human Colon Cancer Cell Line. Indian Journal of Pharmaceutical Education and Research. 54(3s). s570–s579. 3 indexed citations
9.
Samuel, Vijaya Paul, Sunita Dahiya, Yogendra Singh, et al.. (2019). A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia. Chemico-Biological Interactions. 306. 117–122. 11 indexed citations
10.
Gilhotra, Ritu, et al.. (2018). Amorphous solid dispersion: a promising technique for improving oral bioavailability of poorly water-soluble drugs. 85(1). 50–56. 6 indexed citations
11.
Gilhotra, Ritu, et al.. (2018). Gastroretentive drug delivery systems a potential approach for antihypertensive drugs: An updated review. Asian Pacific Journal of Health Sciences. 5(2). 217–223. 1 indexed citations
12.
Gilhotra, Ritu, et al.. (2018). The POTENTIAL OF CAESALPINIA CRISTA LEAVES IN THE TREATMENT OF ULCERATIVE COLITIS IN LABORATORY ANIMALS. Journal of Drug Delivery and Therapeutics. 8(5). 374–381. 1 indexed citations
13.
Gilhotra, Ritu, et al.. (2018). ANTICONVULSANT AND SEDATIVE ACTIVITIES OF EXTRACTS OF CARISSA CARANDAS LEAVES.. Journal of Drug Delivery and Therapeutics. 8(5). 369–373. 5 indexed citations
14.
Gilhotra, Ritu, et al.. (2014). A clinical perspective on mucoadhesive buccal drug delivery systems. Journal of Biomedical Research. 28(2). 81–81. 98 indexed citations
15.
Prabhakaran, R., et al.. (2012). Formulation and Evaluation of Cephalexin Extended-release Matrix Tablets Using Hydroxy Propyl Methyl Cellulose as Rate-controlling Polymer. Journal of Young Pharmacists. 4(1). 3–12. 10 indexed citations
16.
Gilhotra, Ritu, et al.. (2011). Design and characterization of bioadhesive ophthalmic films of flurbiprofen. The Thai Journal of Pharmaceutical Sciences. 35(1). 29–39. 1 indexed citations
17.
Gilhotra, Ritu, et al.. (2011). Formulation and Evaluation of Cephalexin Extended Release Matrix Tablets Using 32 Factorial Design. Journal of Young Pharmacists. 3(4). 259–266. 8 indexed citations
18.
Gilhotra, Ritu, Neeraj Gilhotra, & Debabrata Mishra. (2009). Piroxicam Bioadhesive Ocular Inserts: Physicochemical Characterization and Evaluation in Prostaglandin-Induced Inflammation. Current Eye Research. 34(12). 1065–1073. 22 indexed citations
19.
Gilhotra, Ritu, et al.. (2008). DESIGN AND CHARACTERIZATION OF BIOADHESIVE IN-SITU GELLING OCULAR INSERTS OF GATIFLOXACIN SESQUIHYDRATE. DARU Journal of Pharmaceutical Sciences. 16(1). 1–8. 84 indexed citations
20.
Gilhotra, Ritu & Debabrata Mishra. (2008). Alginate-chitosan film for ocular drug delivery: effect of surface cross-linking on film properties and characterization.. PubMed. 63(8). 576–9. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026